A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
Study NCT01319019
Information provided by GlaxoSmithKline
First Received on March 3, 2011.
Last Updated on March 29, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
